Quantcast

Latest National Institute of Health Stories

2014-06-06 12:24:27

SANTA MONICA, Calif., June 6, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced that it has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) to certain intellectual property related to T Cell Receptor (TCR)-based product candidates that target the NY-ESO-1 antigen for the treatment of cancers expressing...

2014-06-04 16:25:39

Collaboration among Experts in Geriatric Research and Care, Older Adults and Caregivers Aims to Stem Debilitating Problem Affecting One in Three Older People WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) and the National Institute on Aging (NIA) of the National Institutes of Health (NIH) today announced a five-year, $30 million national study of the effectiveness of a multi-pronged strategy that includes deploying nurses...

2014-05-20 08:34:22

AADi Initiates NIH Funded Clinical Trial for Patients with Bladder Cancer PACIFIC PALISADES, Calif., May 20, 2014 /PRNewswire/ -- AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology approaches, today announced the inlicensing of ABI-009 from Celgene Corporation (NASDAQ:CELG). ABI-009 is the nanoparticle albumin-bound (nab®) version of the mTOR inhibitor sirolimus or rapamycin and leverages the same technology of the...

2014-05-13 08:31:28

SAN DIEGO, May 13, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that the U.S. Office of Orphan Products Development at the Food and Drug Administration (FDA) has approved the transfer of sponsorship of the Orphan Drug Designation for intrathecal resiniferatoxin (RTX) in the treatment of intractable pain in end-stage disease from the...

2014-05-12 23:03:38

Therapist Researcher Al R Zia of Ann Arbor, MI produced amazing results in his first batch of clinical trials with Parkinson's Disease ended May 1st, 2014 via CranioSacral Integrative therapy. Documented & Logged Research data results shows the symptoms reversal by 31%. Extraordinary achievement. Ann Arbor, MI (PRWEB) May 12, 2014 Extraordinary results in the world we live in, is more of science fiction rather than real Science. Until we focus ourselves on the reversal of symptoms...

2014-05-12 08:32:54

Newly published findings by nationally recognized pediatric cardiologist Dr. Steven Lipshultz provide "very hopeful" evidence that survivors of often fatal ailment can regain "normal size and function" of disease-damaged areas of heart. DETROIT, May 12, 2014 /PRNewswire-USNewswire/ -- After two decades of arduous research, a National Institutes of Health (NIH)-funded investigator at the Children's Hospital of Michigan (CHM) at the Detroit Medical Center (DMC) and the Wayne State...

2014-05-08 23:10:46

Federal agency responsible for ensuring clinical trials are properly conducted only opened one investigation in all of 2013 and other enforcement activity has significantly declined in recent years, Atlantic Information Services’ Report on Research Compliance exclusively reports in its May issue, based on RRC’s analysis of data from the U.S. Department of Health and Human Services. Washington, DC (PRWEB) May 08, 2014 Perhaps chastened by last year’s public battle with the National...

2014-05-08 16:28:20

BRONX, N.Y., May 8, 2014 /PRNewswire-USNewswire/ -- Two risk factors - getting older and eating poorly - are implicated in more than 80 percent of colon cancer cases in developed countries. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have received a $3.2 million grant from the National Institutes of Health (NIH) to investigate how aging and poor nutrition interact to cause the mutations responsible for driving colon cancer development....

2014-05-05 08:27:56

SBIR Grant from the National Institutes of Neurological Diseases and Stroke Provides Funds for IND-enabling Studies of Lpathomab SAN DIEGO, May 5, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the National Institutes of Neurological Diseases and Stroke (NINDS) that it has been awarded a $1.7 million, 2.5-year grant to develop its antibody therapeutic, Lpathomab(TM), which is directed...

2014-05-01 23:02:45

Mahan Rykiel Associates (MRA), the design firm for The Children’s Inn at NIH’s Play Park was recognized with an Honor award from the Maryland Chapter of the American Society of Landscape Architects. Bethesda, MD (PRWEB) May 01, 2014 Mahan Rykiel Associates (MRA), the design firm for The Children’s Inn at NIH’s Play Park was recognized with an Honor award from the Maryland Chapter of the American Society of Landscape Architects. The Baltimore based landscape architecture, urban...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related